| Serial Number | 97645177 |
| Word Mark | IMMIX BIOPHARMA |
| Filing Date | Monday, October 24, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 5, 2023 |
| Registration Number | 7234591 |
| Registration Date | Tuesday, December 5, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 19, 2023 |
| Goods and Services | providing medical information about the treatment of cancer; providing medical information about the treatment of immuno-dysregulated diseases; providing a website featuring healthcare and medical information, namely, information about cancer and the treatment of cancer; providing a website featuring healthcare and medical information, namely, information about immuno-dysregulated diseases and the treatment of immuno-dysregulated diseases |
| Disclaimer with Predetermined Text | "BIOPHARMA" |
| Goods and Services | scientific research in the field of oncology; scientific research in the field of immuo-dysregulated diseases; development of pharmaceutical preparations and medicines for the treatment of cancer; development of pharmaceutical preparations and medicines for the treatment of immuno-dysregulated diseases; clinical research in the field of oncology; clinical research in the field of immuo-dysregulated diseases; research and development services in the field of anti-cancer preparations; research and development services in the field of preparations for treating immuno-dysregulated diseases; pharmaceutical drug design, product engineering, pharmaceutical research, pharmaceutical drug development and pharmaceutical product quality testing services for others in the field of oncology; pharmaceutical drug design, product engineering, pharmaceutical research, pharmaceutical drug development and pharmaceutical product quality testing services for others in the field of immuno-dysregulated diseases; providing information regarding medical research relating to oncology; providing information regarding medical research relating to immuno-dysregulated diseases |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 7, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, December 31, 2012 |
| First Use In Commerce Date | Tuesday, October 15, 2013 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 7, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | Monday, December 31, 2012 |
| First Use In Commerce Date | Tuesday, October 15, 2013 |
| Party Name | Immix Biopharma, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Los Angeles, CA 90064 |
| Party Name | Immix Biopharma, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Los Angeles, CA 90064 |
| Party Name | Immix Biopharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Los Angeles, CA 90064 |
| Event Date | Event Description |
| Tuesday, December 5, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, December 5, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 19, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 19, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 30, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, August 10, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, August 10, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, August 10, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 10, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 10, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, August 7, 2023 | ASSIGNED TO EXAMINER |
| Monday, November 7, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 27, 2022 | NEW APPLICATION ENTERED |